MDM2 expression during mouse embryogenesis and the requirement of p53

Mechanisms of Development

Volumn 74, Issue 1-2, 1998, Pages 189-193

  Léveillard, Thierry ^a   Gorry, Philippe ^a   Niederreither, Karen ^a   Wasylyk, Bohdan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Apoptosis; Bronchi; CIP1; Eustachian tube; In situ hybridisation; Kidney cortex; Lens; Lung; MDM2; MDM2 protein; Nasopharynx; Neural tube; Oesophagus; Oncogene; p21; p53; p53 null; p53 independent expression; pRb; Respiratory epithelium; Retina; Sinus; Teeth; Testes; Thymus; Trachea; Tumour suppressor; WAF1; Western blot

Indexed keywords

PROTEIN P53; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; FETOPROTEIN; MDM2 PROTEIN, MOUSE; NERVE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MDM2;

ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; LETHALITY; MOUSE; NEURAL TUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TESTIS; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GESTATIONAL AGE; HEAD; IN SITU HYBRIDIZATION; INCISOR; METABOLISM; MOUSE MUTANT; NERVOUS SYSTEM; PHYSIOLOGY; PRENATAL DEVELOPMENT; TUMOR SUPPRESSOR GENE; VISCERA;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FETAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, P53; GESTATIONAL AGE; HEAD; IN SITU HYBRIDIZATION; INCISOR; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VISCERA;

EID: 0032102824     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(98)00074-4     Document Type: Article

References (26)

1. Almog N., Rotter V. Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta. 1333:1997;F1-27.
2. An W.G., Kanekal M., Simon M.C., Maltepe E., Blagosklonny M.V., Neckers L.M. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 392:1998;405-408.
3. Armstrong J.F., Kaufman M.H., Harrison D.J., Clarke A.R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:1995;931-936.
4. Décimo, D., Georges-Labouesse, E., Dollé, P., 1995. In situ hybridization of nucleic acid probes to cellular RNA. In: Hames, B.D., Higgins S.J. (Eds.), Genes Probes 2. IRC, London, pp. 183-205.
5. Haines D.S. The mdm2 proto-oncogene. Leuk. Lymphoma. 26:1997;227-238.
6. Hall P.A., Lane D.P. Tumor suppressors: a developing role for p53? Curr. Biol. 7:1997;R144-R147.
7. Hansen R., Oren M. p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7:1997;46-51.
8. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
9. Howes K.A., Ransom N., Papermaster D.S., Lasudry J.G., Albert D.M., Windle J.J. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53 (published erratum appears in Genes Dev. 1994, 8(14):1738). Genes Dev. 8:1994;1300-1310.
10. Ibrahim A.P., Gallimore P.H., Grand R.J. The expression of MDM2 and other p53-regulated proteins in the tissues of the developing rat. Biochim. Biophys. Acta. 1350:1997;306-316.
11. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature. 378:1995;206-208.
12. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
13. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
14. Midgley C.A., Lane D.P. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene. 15:1997;1179-1189.
15. Momand J., Zambetti G.P. Mdm-2: 'big brother' of p53. J. Cell Biochem. 64:1997;343-352.
16. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 378:1995;203-206.
17. Montes de Oca Luna R., Tabor A.D., Eberspaecher H., Hulboy D.L., Worth L.L., Colman M.S., Finlay C.A., Lozano G. The organization and expression of the mdm2 gene. Genomics. 33:1996;352-357.
18. 35S-labelled probes for retinoid receptors. In: Redfern, C.P.F. (Ed.), Methods in Molecular Biology. Humana, Totowa, NJ, pp. 247-267.
19. Nicol C.J., Harrison M.L., Laposa R.R., Gimelshtein I.L., Wells P.G. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice (published erratum appears in Nat. Genet. 1995, 1(1):104). Nat. Genet. 10:1995;181-187.
20. Norimura T., Nomoto S., Katsuki M., Gondo Y., Kondo S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2:1996;577-580.
21. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., Bradley A., Olson E.N., Harper J.W., Elledge S.J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024-1027.
22. Piette J., Neel H., Marechal V. Mdm2: keeping p53 under control. Oncogene. 15:1997;1001-1010.
23. Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.W., Cordon-Cardo C., DePinho R.A. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 92:1998;713-723.
24. Sah V.P., Attardi L.D., Mulligan G.J., Williams B.O., Bronson R.T., Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10:1995;175-180.
25. Schmid P., Lorenz A., Hameister H., Montenarh M. Expression of p53 during mouse embryogenesis. Development. 113:1991;857-865.
26. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:1998;725-734.